Cornerstone Advisory
ABBV icon

Cornerstone Advisory’s AbbVie ABBV Stock Holding History

Cornerstone Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.28M Buy
16,358
+156
+1% +$40K 0.33% 57
2026
Q2 		$4.08M Buy
16,202
+152
+0.9% +$32.7K 0.34% 54
2026
Q1 		$3.49M Buy
16,050
+73
+0.5% +$16.2K 0.33% 55
2025
Q4 		$3.65M Buy
15,977
+135
+0.9% +$30.8K 0.35% 54
2025
Q3 		$3.67M Buy
15,842
+258
+2% +$52.5K 0.36% 53
2025
Q2 		$2.89M Sell
15,584
-22
-0.1% -$4.09K 0.31% 54
2025
Q1 		$2.92M Sell
15,606
-210
-1% -$40.8K 0.34% 53
2024
Q4 		$3.05M Buy
15,816
+230
+1% +$42.3K 0.35% 53
2024
Q3 		$3.08M Sell
15,586
-401
-3% -$74.8K 0.41% 52
2024
Q2 		$2.74M Sell
15,987
-5,137
-24% -$851K 0.39% 52
2024
Q1 		$3.85M Buy
21,124
+16
+0.1% +$2.76K 0.55% 44
2023
Q4 		$3.27M Buy
21,108
+795
+4% +$116K 0.51% 44
2023
Q3 		$3.03M Buy
20,313
+94
+0.5% +$13.8K 0.53% 40
2023
Q2 		$2.72M Sell
20,219
-244
-1% -$35.8K 0.48% 42
2023
Q1 		$3.26M Buy
20,463
+1,798
+10% +$275K 0.59% 34
2022
Q4 		$3.02M Sell
18,665
-1,495
-7% -$229K 0.59% 36
2022
Q3 		$2.71M Buy
20,160
+2,281
+13% +$327K 0.6% 34
2022
Q2 		$2.74M Sell
17,879
-14,850
-45% -$2.27M 0.63% 34
2022
Q1 		$5.31M Sell
32,729
-6
-0% -$872 0.81% 26
2021
Q4 		$4.43M Sell
32,735
-73
-0.2% -$8.62K 0.64% 30
2021
Q3 		$3.54M Sell
32,808
-619
-2% -$70.7K 0.59% 35
2021
Q2 		$3.76M Buy
33,427
+3,384
+11% +$381K 0.63% 35
2021
Q1 		$3.25M Sell
30,043
-1,881
-6% -$201K 0.62% 35
2020
Q4 		$3.42M Buy
31,924
+1,271
+4% +$122K 0.69% 36
2020
Q3 		$2.68M Buy
30,653
+19,374
+172% +$1.82M 0.63% 41
2020
Q2 		$1.11M Buy
11,279
+5,927
+111% +$522K 0.29% 65
2020
Q1 		$408K Buy
+5,352
New +$456K 0.12% 104

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Cornerstone Advisory's ABBV Position: Q3 2026 in Review

Cornerstone Advisory increased its AbbVie (ABBV) stake by 0.96% in Q3 2026, buying an estimated $40K and bringing the position to 16,358 shares worth $4.28M. The position accounts for 0.33% of the portfolio, ranked #57.

Cornerstone Advisory first reported a position in ABBV in Q1 2020 and has held it in 27 quarters since. The position peaked at $5.31M in Q1 2022. 2,757 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Cornerstone Advisory held 16,358 shares of AbbVie worth $4.28M as of Q3 2026.
  • Cornerstone Advisory bought 156 AbbVie shares in Q3 2026, an estimated $40K.
  • AbbVie made up 0.33% of Cornerstone Advisory's portfolio in Q3 2026, its #57 holding.
  • Cornerstone Advisory first reported a position in AbbVie in Q1 2020 and has held it in 27 quarters since.
  • Cornerstone Advisory's AbbVie position peaked at $5.31M in Q1 2022.
  • 2,757 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Cornerstone Advisory's 13F filing for Q3 2026, filed 6 Nov 2026.